Free Account Opening + AMC Free Demat
Loading...

Mangal Compusolution IPO vs Onyx Biotec IPO

Comparision between Mangal Compusolution IPO and Onyx Biotec IPO.

IPO Details

Mangal Compusolution IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Onyx Biotec IPO is a SME Book Built Issue proposed to list at NSE SME.

  Mangal Compusolution IPO Onyx Biotec IPO
Logo Mangal Compusolution IPO Logo Onyx Biotec IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Jawa Capital Services Private Limited Horizon Management Private Limited
Registrar Kfin Technologies Limited Mas Services Limited
Market Maker Rikhav Securities Limited Giriraj Stock Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Mangal Compusolution IPO is up to ₹16.23 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹29.34 Cr. The final issue price of Mangal Compusolution IPO is ₹45.00 per share and of Onyx Biotec IPO is ₹61.00 per share.

  Mangal Compusolution IPO Onyx Biotec IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹58.00 per share
Issue Price (Upper) ₹61.00 per share
Issue Price (Final) ₹45.00 per share ₹61.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 3000 shares 2000 shares
Fresh Issue Size 36,06,000 shares 48,10,000 shares
Fresh Issue Size (Amount) up to ₹16.23 Cr up to ₹29.34 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 36,06,000 shares 48,10,000 shares
Issue Size Total (Amount) up to ₹16.23 Cr up to ₹29.34 Cr

IPO Timetable

Mangal Compusolution IPO opens on Nov 12, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of Mangal Compusolution IPO and Onyx Biotec IPO is Nov 14, 2024, and Nov 18, 2024, respectively.

  Mangal Compusolution IPO Onyx Biotec IPO
Anchor Bid Date Nov 12, 2024
Issue Open Nov 12, 2024 Nov 13, 2024
Issue Close Nov 14, 2024 Nov 18, 2024
Basis Of Allotment (Tentative) Nov 18, 2024 Nov 19, 2024
Initiation of Refunds (Tentative) Nov 19, 2024 Nov 20, 2024
Credit of Share (Tentative) Nov 19, 2024 Nov 20, 2024
Listing date (Tentative) Nov 21, 2024 Nov 22, 2024
Anchor Lockin End date 1 Dec 19, 2024
Anchor Lockin End date 2 Feb 17, 2025

Financials

Mangal Compusolution IPO P/E ratio is 11.66, as compared to Onyx Biotec IPO P/E ratio of 26.81.

  Mangal Compusolution IPO Onyx Biotec IPO
Financial

Mangal Compusolution Limited Financial Information (Restated)

Mangal Compusolution Limited's revenue decreased by -32.69% and profit after tax (PAT) dropped by -45.21% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended30 Jun 202431 Mar 202431 Mar 202331 Mar 2022
Assets4,492.014,552.124,715.715,267.09
Revenue453.442,344.423,483.181,848.78
Profit After Tax80.97385.80704.0986.62
Net Worth2,080.881,999.901,614.10910.00
Reserves and Surplus1,080.88999.901,414.10710.00
Total Borrowing1,862.752,041.212,652.303,434.12
Amount in ₹ Lakhs

Onyx Biotec Limited Financial Information (Restated)

Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended31 May 202431 Mar 202431 Mar 202331 Mar 2022
Assets7,476.577,413.585,872.363,683.84
Revenue1,054.115,387.433,961.654,498.09
Profit After Tax130.77303.16184.46335.29
Net Worth2,618.642,487.871,820.161,637.59
Reserves and Surplus1,286.421,155.651,230.001,047.43
Total Borrowing3,156.143,078.042,922.831,224.39
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 100.00% 88.60%
Promoter Shareholding (Post-Issue) 73.50%
P/E Ratio 11.66 26.81
Market Cap ₹61.23 Cr. ₹110.61 Cr.
ROE 3.97%% 4.99%%
ROCE 2.05%% 3.71%%
Debt/Equity 0.9 1.21
EPS ₹3.86 ₹2.28
RoNW 15.56%% 4.99%%

Shares Offered

In the Mangal Compusolution IPO retail investors (RII) are offered 17,10,000 shares while in Onyx Biotec IPO retail investors are offered 17,10,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Mangal Compusolution IPO and 9,12,000 shares in Onyx Biotec IPO.

  Mangal Compusolution IPO Onyx Biotec IPO
Anchor Investor Reserveration 13,66,000 shares
Market Maker Reserveration 1,86,000 shares 2,44,000 shares
QIB 0 shares 9,12,000 shares
NII 17,10,000 shares 6,88,000 shares
RII 17,10,000 shares 16,00,000 shares
Employee 0 shares 0 shares
Others
Total 34,20,001 shares 32,00,000 shares

Bids Received (Subscription)

Mangal Compusolution IPO subscribed 34.59x in total, whereas Onyx Biotec IPO subscribed 198.00x.

  Mangal Compusolution IPO Onyx Biotec IPO
QIB (times) 32.49x
NII (times) 22.28x 602.86x
Big NII (times)
Small NII (times)
RII (times) 46.91x 118.26x
Employee (times)
Other (times)
Total (times) 34.59x 198.00x

Comments

Add a public comment...